Pixie Dust Technologies, Inc. announced a joint research agreement with Tohoku University School of Medicine (the "University") for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -5.71% | -19.84% | -71.63% |
May. 31 | Pixie Dust Technologies, Inc. Announces Debt Financing | CI |
May. 28 | Pixie Dust Technologies, Inc. Provides Earning Guidance for the Fiscal Year Ended April 30, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-71.63% | 29.11M | |
-17.81% | 181B | |
+2.65% | 169B | |
+3.95% | 156B | |
+8.31% | 103B | |
+36.74% | 84.96B | |
+13.54% | 83.78B | |
-0.60% | 76.05B | |
-2.36% | 46.42B | |
-34.07% | 43.93B |
- Stock Market
- Equities
- PXDT Stock
- News Pixie Dust Technologies, Inc.
- Pixie Dust Technologies, Inc. Announces Collaborative Research Agreement with Tohoku University School of Medicine